Stocktoria
AtriCure, Inc. ATRC
AtriCure, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $534.5M | $465.3M | $399.2M | $330.4M | $274.3M | $206.5M | $230.8M | $201.6M | $174.7M | $155.1M |
| Gross profit | $400.8M | $347.5M | $300.4M | $245.9M | $205.9M | $149.3M | $170.3M | $147.1M | $126.2M | $111.1M |
| R&D expense | $99.2M | $96.2M | $73.9M | $57.3M | $48.5M | $43.1M | $41.2M | $34.7M | $34.1M | $35.8M |
| SG&A expense | $311.0M | $291.4M | $253.1M | $231.3M | $204.6M | $150.8M | $167.1M | $129.5M | $117.0M | $106.4M |
| Operating income | -$9.4M | -$40.0M | -$26.7M | -$42.7M | $55.2M | -$44.2M | -$33.1M | -$17.1M | -$25.0M | -$31.1M |
| Interest expense | — | — | $6.9M | $5.0M | $4.9M | $4.9M | $4.1M | $4.6M | $2.3M | $1.8M |
| Income tax | $1.3M | $1.0M | $591,000 | $268,000 | $188,000 | $114,000 | $199,000 | $226,000 | $14,000 | $40,000 |
| Net income | -$11.4M | -$44.7M | -$30.4M | -$46.5M | $50.2M | -$48.2M | -$35.2M | -$21.1M | -$26.9M | -$33.3M |
| EPS (diluted) | $-0.24 | $-0.95 | $-0.66 | $-1.02 | $1.09 | $-1.14 | $-0.94 | — | — | — |
| Operating cash flow | $57.3M | $12.2M | $4.5M | -$22.1M | -$13.8M | -$19.9M | -$15.8M | -$4.2M | -$8.9M | -$15.1M |
| Free cash flow | $48.3M | $745,000 | -$7.5M | -$39.0M | -$23.5M | -$25.1M | -$28.0M | -$10.4M | -$15.3M | -$22.8M |
| Cash & equivalents | $167.4M | $122.7M | $84.3M | $58.1M | $43.7M | $41.9M | $28.5M | $32.2M | $21.8M | $24.2M |
| Inventory | $78.5M | $75.3M | $67.9M | $45.9M | $39.0M | $35.0M | $29.4M | $22.5M | $22.5M | $17.7M |
| Total assets | $654.2M | $609.3M | $613.9M | $585.4M | $615.3M | $714.5M | $557.9M | $356.8M | $267.7M | $276.4M |
| Total liabilities | $162.2M | $148.4M | $147.8M | $128.7M | $131.6M | $302.1M | $310.5M | $107.4M | $106.5M | $108.0M |
| Shareholders' equity | $491.9M | $461.0M | $466.2M | $456.8M | $483.8M | $412.4M | $247.3M | $249.4M | $161.2M | $168.4M |
Growth · year-over-year · Revenue CAGR 14.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +14.9% | +16.5% | +20.8% | +20.4% | +32.8% | -10.5% | +14.5% | +15.4% | +12.6% | +19.5% |
| Net income growth | — | — | — | -192.6% | — | — | — | — | — | — |
| EPS growth | — | — | — | -193.6% | — | — | — | — | — | — |
| Free cash flow growth | +6381.1% | — | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.